Market Closed -
Nasdaq Helsinki
12:29:33 2024-03-28 pm EDT
5-day change
1st Jan Change
3.95
EUR
-0.75%
-8.14%
+6.33%
Sales 2024 *
16.79M
18.11M
Sales 2025 *
25.35M
27.35M
Capitalization
70.22M
75.76M
Net income 2024 *
-3M
-3.24M
Net income 2025 *
-2M
-2.16M
EV / Sales 2024 *
4.24
x
Net Debt
2024
*
965K
1.04M
Net Debt
2025
*
4.58M
4.94M
EV / Sales 2025 *
2.95
x P/E ratio 2024 *
-18
x
P/E ratio 2025 *
-25.5
x
Employees
114
Yield 2024 *
-
Yield 2025 *
-
Free-Float
87.31%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Transcript : Optomed Oyj, 2023 Earnings Call, Feb 15, 2024
Feb. 15
Optomed Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 15
CI
Optomed Oyj Provides Revenue Guidance for the Full Year 2024
Feb. 15
CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 15
CI
Optomed Oyj Announces Nomination Board
Jan. 10
CI
Transcript : Optomed Oyj, Nine Months 2023 Earnings Call, Nov 03, 2023
Nov. 03
Optomed Oyj Provides Revenue Guidance for the Year 2023
Nov. 03
CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 03
CI
Optomed to Raise EUR4 Million Via Share Issue
23-09-21
MT
Optomed plc Announces Composition of Its Nomination Board
23-09-12
CI
Optomed to Supply Large Diabetic Retinopathy Screening Solution to Spain
23-08-18
CI
Transcript : Optomed Oyj, H1 2023 Earnings Call, Aug 04, 2023
23-08-04
Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-04
CI
Optomed Appoints Juho Himberg as the New CEO, Effective October 1, 2023
23-08-03
CI
Optomed Announces CEO Transition Plan
23-06-14
CI
More news
AVIS D'ANALYSTES DU JOUR : Stellantis, Schneider, Renault, Safran, Airbus, Valeo,Gecina, FDJ...
Feb. 16
Wall Street plane, le luxe atterrit en catastrophe
23-09-26
AVIS D'ANALYSTES DU JOUR : Kering, Axa, Eurofins, Hermès, Scor, Nexi, Fnac, Aperam, ArgenX...
23-09-26
Small Caps : les derniers choix des stars de la gestion
22-02-17
More news 1 day -0.75%
1 week -8.14%
Current month +12.86%
1 month +19.52%
3 months +8.52%
6 months +48.22%
Current year +6.33%
More quotes
Managers
Title Age Since
Chief Executive Officer
54
23-09-30
Director of Finance/CFO
40
18-12-31
Chief Tech/Sci/R&D Officer
-
-
Members of the board
Title Age Since
Chairman
66
05-12-31
Director/Board Member
72
18-12-31
Director/Board Member
68
18-12-31
More insiders
Date
Price
Change
Volume
24-03-28
3.95
-0.75%
19,563
24-03-27
3.98
0.00%
29,948
24-03-26
3.98
-0.25%
32,684
24-03-25
3.99
-0.75%
25,730
24-03-22
4.02
-5.52%
62,753
Delayed Quote
Nasdaq Helsinki, March 28, 2024 at 12:29 pm EDT
More quotes
Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
More about the company
Last Close Price
3.95
EUR
Average target price
5.8
EUR
Spread / Average Target
+46.84%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1